Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
General Practice · ANASCO, PR · NPI 1558341487
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 531 | 84 |
| Synthroid | Levothyroxine Sodium | 434 | 59 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 413 | 117 |
| Famotidine | Famotidine | 274 | 53 |
| Montelukast Sodium | Montelukast Sodium | 236 | 41 |
| Atorvastatin Calcium | Atorvastatin Calcium | 200 | 59 |
| Losartan Potassium | Losartan Potassium | 185 | 55 |
| Alendronate Sodium | Alendronate Sodium | 176 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 166 | 34 |
| Lisinopril | Lisinopril | 163 | 47 |
| Duloxetine Hcl | Duloxetine Hcl | 161 | 29 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 158 | 23 |
| Amlodipine Besylate | Amlodipine Besylate | 157 | 49 |
| Metformin Hcl | Metformin Hcl | 154 | 48 |
| Tradjenta | Linagliptin | 154 | 32 |
| Omeprazole | Omeprazole | 145 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 137 | 29 |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 135 | 29 |
| Temazepam | Temazepam | 119 | 18 |
| Furosemide | Furosemide | 117 | 27 |
| Sertraline Hcl | Sertraline Hcl | 111 | 20 |
| Glimepiride | Glimepiride | 104 | 33 |
| Ezetimibe | Ezetimibe | 99 | 27 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 96 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 94 | 22 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 94 | 12 |
| Levothyroxine Sodium | Levothyroxine Sodium | 93 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 92 | 27 |
| Allopurinol | Allopurinol | 73 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 72 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 71 | 18 |
| Baclofen | Baclofen | 68 | 26 |
| Hydrochlorothiazide | Hydrochlorothiazide | 67 | 16 |
| Humalog | Insulin Lispro | 66 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 65 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 64 | 15 |
| Etodolac | Etodolac | 62 | 29 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 20 |
| Pentoxifylline | Pentoxifylline | 56 | 11 |
| Trazodone Hcl | Trazodone Hcl | 55 | 16 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 54 | 13 |
| Meloxicam | Meloxicam | 52 | 14 |
| Clonazepam | Clonazepam | 51 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 51 | suppressed |
| Simvastatin | Simvastatin | 51 | 17 |
| Celecoxib | Celecoxib | 47 | 13 |
| Enalapril Maleate | Enalapril Maleate | 47 | 12 |
| Finasteride | Finasteride | 46 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 43 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 42 | 17 |
| Memantine Hcl | Memantine Hcl | 42 | suppressed |
| Lansoprazole | Lansoprazole | 40 | suppressed |
| Eliquis | Apixaban | 39 | suppressed |
| Latanoprost | Latanoprost | 35 | suppressed |
| Lumigan | Bimatoprost | 35 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 32 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 32 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 31 | 26 |
| Jardiance | Empagliflozin | 31 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | suppressed |
| Carvedilol | Carvedilol | 30 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 29 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 29 | 21 |
| Breo Ellipta | Fluticasone/Vilanterol | 28 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 28 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 27 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 27 | suppressed |
| Spironolactone | Spironolactone | 25 | suppressed |
| Sucralfate | Sucralfate | 25 | suppressed |
| Trulicity | Dulaglutide | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 23 | 15 |
| Humulin N | Insulin Nph Human Isophane | 23 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 21 | 21 |
| Clotrimazole | Clotrimazole | 21 | 14 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 21 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Calcitriol | Calcitriol | 20 | suppressed |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Advocate Syringes | Syringe-Needle,insulin,0.5 Ml | 19 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Humulin R | Insulin Regular, Human | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Naproxen | Naproxen | 19 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 19 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Humira(Cf) Pen | Adalimumab | 17 | suppressed |
| Lorazepam | Lorazepam | 17 | suppressed |
| Prednisone | Prednisone | 17 | 16 |
| Bumetanide | Bumetanide | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 13 |
| Nystatin | Nystatin | 15 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Sulindac | Sulindac | 14 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Nabumetone | Nabumetone | 12 | suppressed |
| Rinvoq | Upadacitinib | 12 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Atenolol | Atenolol | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error